From vampire legends to lab-grown tissue, the idea that young blood can reverse aging is no longer pure myth. A new study shows that proteins secreted by bone marrow cells, triggered by young blood, can rejuvenate aging skin in the lab.| New Atlas
Fragile X syndrome research is advancing in 2025 with new FRAXA-funded grants supporting breakthrough science, therapy platforms, and clinical tools. The post Fragile X Syndrome Research in 2025: FRAXA Announces New Grants & Promising Leads appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.| FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome
UMass Chan Medical School licenses RNA-based Fragile X treatment approach using ASOs to QurAlis, moving a groundbreaking gene-targeted therapy closer to human clinical trials. The post UMass Chan Medical School Licenses RNA-Based Therapy to QurAlis, Advancing a New Era in Fragile X Treatment appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.| FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome
Dr. Jeannie Lee, a leading expert in epigenetics and gene regulation at Harvard Medical School and Massachusetts General Hospital, has been awarded a Blavatnik Therapeutics Challenge Award, including $1 million in funding, to expand her groundbreaking work on reactivating the The post Harvard’s Dr. Jeannie Lee Wins $1M Award to Develop Gene Reactivation Therapy for Fragile X appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.| FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome
‘Human organ avatars’ to take centre stage at EMBL’s third annual Kafatos Lecture.| EMBL